New York had previously reached a settlement with the Sacklers and Purdue for $5.4 billion, which was ultimately derailed by a U.S. Supreme Court decision in 2024.

The deal is still being finalized and requires court approval, James said. Once the deal goes through, New York’s opioid settlement fund to support opioid treatment and recovery programs ...